Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism
Jiasi Zhang, Yu-xi Liu, Qun Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112747-112747
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 24
Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases
Yonghui Lv, Meiying Wu, Zhe Wang, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 3, pp. 827-851
Closed Access | Times Cited: 49
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
HDAC inhibitor enhances ferroptosis susceptibility of AML cells by stimulating iron metabolism
Rui Bian, Yingying Shang, Nahua Xu, et al.
Cellular Signalling (2025) Vol. 127, pp. 111583-111583
Closed Access | Times Cited: 1
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 250-250
Open Access | Times Cited: 19
Frontiers of ferroptosis research: An analysis from the top 100 most influential articles in the field
Kunming Cheng, Qiang Guo, Zefeng Shen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)
Zhaomu Zeng, Yueyue Chen, Xiuchao Geng, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 23
Apigenin, a natural flavonoid, promotes autophagy and ferroptosis in human endometrial carcinoma Ishikawa cells in vitro and in vivo
Yan-Cui Liang, Qian Zhong, Run-Hui Ma, et al.
Food Science and Human Wellness (2023) Vol. 12, Iss. 6, pp. 2242-2251
Open Access | Times Cited: 16
Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma
Joelle C. Boulos, Ejlal A. Omer, Daniela Rigano, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 11, pp. 2265-2281
Open Access | Times Cited: 15
Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis
Dan Wang, Fenglin Wang, Haixia Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 8, pp. 3446-3460
Open Access | Times Cited: 14
Evaluation of Ferroptosis-Based Anti-Leukemic Activities of ZnO Nanoparticles Synthesized by a Green Route Against Pre-B Acute Lymphoblastic Leukemia Cells (Nalm-6 and REH)
Muhammad Hossein Ashoub, Mahnaz Amiri, Ahmad Fatemi, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36608-e36608
Closed Access | Times Cited: 6
Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies
Hanyun Zhang, Chunjie Sun, Qi Sun, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Induction of ferroptosis cell death in acute promyelocytic leukemia cell lines (NB4 and HL-60) using hydrothermally synthesized ZnO NPs in the presence of black cardamom extract
Muhammad Hossein Ashoub, Mahnaz Amiri, Razieh Razavi, et al.
Results in Engineering (2023) Vol. 20, pp. 101479-101479
Open Access | Times Cited: 13
Targeting regulated cell death pathways in acute myeloid leukemia
Sylvain Garciaz, Thomas A. Miller, Yves Collette, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 1, pp. 151-168
Open Access | Times Cited: 12
HSPA9 contributes to tumor progression and ferroptosis resistance by enhancing USP14-driven SLC7A11 deubiquitination in multiple myeloma
Na Shen, Yuan Xia, Xuxing Shen, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115720-115720
Open Access
Ferrostatin-1 mitigates ionizing radiation-induced intestinal injuries by inhibiting apoptosis and ferroptosis: an in vitro and in vivo study
Xinyue Wang, Wenxuan Li, Yinping Dong, et al.
International Journal of Radiation Biology (2023) Vol. 99, Iss. 10, pp. 1607-1618
Closed Access | Times Cited: 9
CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia
Adam Nopora, Ulrich H. Weidle
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 2, pp. 118-136
Open Access | Times Cited: 3
Design, Synthesis, Electrochemical, and Biological Evaluation of Fluorescent Chlorido[N,N′-bis(methoxy/hydroxy)salicylidene-1,2-bis(4-methoxyphenyl)ethylenediamine]iron(III) Complexes as Anticancer Agents
Astrid Dagmar Bernkop-Schnürch, Donja Chavooshi, Hubert Descher, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15916-15925
Open Access | Times Cited: 5
Over-Expressed GATA-1S, the Short Isoform of the Hematopoietic Transcriptional Factor GATA-1, Inhibits Ferroptosis in K562 Myeloid Leukemia Cells by Preventing Lipid Peroxidation
Silvia Trombetti, Nunzia Iaccarino, Patrizia Riccio, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 537-537
Open Access | Times Cited: 4
Silencing LCN2 enhances RSL3-induced ferroptosis in T cell acute lymphoblastic leukemia
Chuan Tian, Min Zheng, Lan Xiang, et al.
Gene (2023) Vol. 879, pp. 147597-147597
Closed Access | Times Cited: 4
Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy
Leqiang Zhang, Ning Chang, Jia Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Targeted single‐cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis‐resistant state in hematologic malignancies
Xiaohui Shen, Peiyuan Dong, Jingjing Kong, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 8, pp. 1343-1356
Open Access | Times Cited: 3
Unravelling cancer subtype-specific driver genes in single-cell transcriptomics data with CSDGI
Meng Huang, Jiangtao Ma, Guangqi An, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 12, pp. e1011450-e1011450
Open Access | Times Cited: 3
Lnc-TC/miR-142-5p/CUL4B signaling axis promoted cell ferroptosis to participate in benzene hematotoxicity
Jing Ren, Jingyu Wang, Xiaoli Guo, et al.
Life Sciences (2022) Vol. 310, pp. 121111-121111
Closed Access | Times Cited: 5
Artemisinin‐isatin hybrids tethered via ethylene linker and their anti‐lung cancer activity
Ruo Wang, Qianru Zhang, Min Chen
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top